| Dr Bradley Lembcke, MD | |
|
3600 Gaston Ave, #550, Dallas, TX 75246-1904 | |
| (214) 821-1177 | |
| (214) 821-1193 |
| Full Name | Dr Bradley Lembcke |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 3600 Gaston Ave, Dallas, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477583748 | NPI | - | NPPES |
| 87Z678 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | K2350 (Texas) | Primary |
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of Shanghai Datong Medical Information Technology Co., Ltd., a leading drug decision support provider in China.
A new study by an international team of researchers, affiliated with Ulsan National Institute of Science and Technology has announced that they have succeeded for the first time in observing the structural changes in carbonic anhydrase.
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that most often affects older adults. CLL responds to bone marrow stem cell transplantation (allo-HSCT); however, the rate of relapse for CLL remains relatively high.
Biovista Inc. today announced that BVA-201, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-201 is an existing drug that Biovista repositioned in MS and is aimed at neuroprotection. It was shown to have both efficacy in reducing symptoms and no toxic effects in this well established model of MS.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley Lembcke, MD Po Box 849931, Dallas, TX 75284-0001 Ph: (214) 821-1177 | Dr Bradley Lembcke, MD 3600 Gaston Ave, #550, Dallas, TX 75246-1904 Ph: (214) 821-1177 |
News Archive
Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).
Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of Shanghai Datong Medical Information Technology Co., Ltd., a leading drug decision support provider in China.
A new study by an international team of researchers, affiliated with Ulsan National Institute of Science and Technology has announced that they have succeeded for the first time in observing the structural changes in carbonic anhydrase.
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that most often affects older adults. CLL responds to bone marrow stem cell transplantation (allo-HSCT); however, the rate of relapse for CLL remains relatively high.
Biovista Inc. today announced that BVA-201, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-201 is an existing drug that Biovista repositioned in MS and is aimed at neuroprotection. It was shown to have both efficacy in reducing symptoms and no toxic effects in this well established model of MS.
› Verified 1 days ago
Preetha Nair, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 | |
Michael Burton, MD, MSPH Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-3597 | |
Lavanya Ambujaa Dharmarajan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 | |
Roshni Patel, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8230 Walnut Hill Ln Ste 620, Dallas, TX 75231 Phone: 214-373-3475 | |
Dr. Apurva Yeluru, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave Ste 550, Dallas, TX 75246 Phone: 214-820-0111 | |
Dr. Nicholas Ragovis, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 Fax: 212-289-6393 | |
Kenneth Carter Raney, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1441 N Beckley Avenue, Dept Of Medical Education, Dallas, TX 75203 Phone: 214-947-2300 |